The potential of statins as part of anti-cancer treatment
- 31 March 2005
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (4) , 516-522
- https://doi.org/10.1016/j.ejca.2004.12.009
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mutual amplification of apoptosis by statin‐induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cellsBritish Journal of Pharmacology, 2004
- The Risk of Cancer in Users of StatinsJournal of Clinical Oncology, 2004
- Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosisPublished by Elsevier ,2004
- The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal womenCancer, 2004
- Lovastatin inhibits Rho‐regulated expression of E‐selectin by TNF‐α and attenuates tumor cell adhesionThe FASEB Journal, 2003
- Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- p21-dependent Inhibition of Colon Cancer Cell Growth by Mevastatin Is Independent of Inhibition of G1 Cyclin-dependent KinasesJournal of Biological Chemistry, 2003
- Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis‐dependent mechanismInternational Journal of Cancer, 2002
- Dolichol-like lipids with stimulatory effect on DNA synthesis: Substrates for protein dolichylation?Journal of Cellular Biochemistry, 1998
- Increased radioresistance of ejras‐transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylationInternational Journal of Cancer, 1993